Market Tracker

08/25 4:24pm ET

Arbutus Biopharma Corp (NASDAQ:ABUS)

3.66
Delayed Data
As of 4:00pm ET
 -0.13 / -3.43%
Today’s Change
2.72
Today|||52-Week Range
7.72
-17.75%
Year-to-Date

Today’s Trading

Previous close3.79
Today’s open3.81
Day’s range3.60 - 3.85
Volume67,863
Average volume (3 months)148,857
Market cap$207.7M
Dividend yield--
Data as of 4:00pm ET, 08/25/2016

Growth & Valuation

Earnings growth (last year)+25.56%
Earnings growth (this year)-179.00%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+66.34%
P/E ratio--
Price/Sales8.13
Price/Book0.38

Competitors

 Today’s
change
Today’s
% change
EGLTEgalet Corp-0.50-6.08%
VTAEVitae Pharmaceutical...-0.13-1.82%
NYMXNymox Pharmaceutical...+0.44+9.89%
--China Health Group I...-0.00-0.45%
Data as of 4:00pm ET, 08/25/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.52
Annual revenue (last year)$24.9M
Annual profit (last year)-$61.1M
Net profit margin-245.73%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Financial Officer &
Executive Vice President
Bruce G. Cousins
Corporate headquarters
Burnaby, British Columbia

Forecasts